| Jennifer Ann Moss, APRN | |
|
3341 49th Ave E, Bradenton, FL 34203-3945 | |
| (407) 761-2208 | |
| Not Available |
| Full Name | Jennifer Ann Moss |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | 3341 49th Ave E, Bradenton, Florida |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003681487 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 11029730 (Florida) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jennifer Ann Moss, APRN 3341 49th Ave E, Bradenton, FL 34203-3945 Ph: (407) 761-2208 | Jennifer Ann Moss, APRN 3341 49th Ave E, Bradenton, FL 34203-3945 Ph: (407) 761-2208 |
News Archive
UNIVERSITY of Huddersfield researcher Yeshwanth Pulijala is dedicated to bringing about big improvements in medical training by harnessing the power of virtual reality and 3D technology. Now, he is part of a team that has developed the prototype for an innovative tool that will enable doctors to develop their communication skills - including the breaking of bad news - by conducting a simulated interview with a virtual patient.
An estimated 300,000 people in North America are afflicted with dystonia, a disorder characterized by a progressive loss of motor control. Patients with generalized dystonia grapple with involuntary muscle spasms that lead to uncontrolled twisting and turning in awkward, sometimes painful postures.
A new study reports the seroprevalence among schoolchildren in Zurich, Switzerland. Published on the preprint server medRxiv* in September 2020, this study contributes to the current discussion on how and when to reopen schools.
Aeterna Zentaris Inc., a late-stage drug development company specialized in oncology and endocrine therapy, today announced that it has received positive Scientific Advice from the European Medicines Agency (EMA) regarding the Phase 3 trial initiated last April for the development of its lead anticancer proprietary compound, perifosine, in refractory advanced colorectal cancer.
› Verified 5 days ago
Devon Buck, APN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 316 Manatee Ave W, Bradenton, FL 34205 Phone: 941-748-2277 Fax: 941-748-1958 | |
Isabella A Biringer, ARNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3904 Cortez Rd W, Bradenton, FL 34210 Phone: 941-345-1943 Fax: 941-345-1944 | |
Amber Swartz, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 11505 Rangeland Pkwy, Bradenton, FL 34211 Phone: 941-907-6016 Fax: 941-907-0199 | |
Karen M Bethune, ARNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1850 59th St W, Blake Park Ste B, Bradenton, FL 34209 Phone: 941-792-4993 Fax: 941-795-2905 | |
Jennifer C Eziefuoh, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 8610 State Road 70 E, Bradenton, FL 34202 Phone: 941-242-1929 Fax: 941-242-5116 | |
Tanasia Chicole Thomas, MPH, MSN, APRN-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 7155 Chatum Light Run, Bradenton, FL 34212 Phone: 941-580-2890 |